NEW STEP BY STEP MAP FOR API PRODUCTS

In precisely the same year the ITC also reported on their own efforts towards the movement syntheses of two direct compounds described previously by AstraZeneca. The first a single facts the flow synthesis of a strong 5HT1B antagonist (28) which was assembled through a 5 move constant synthesis such as a SNAr response, heterogeneous hydrogenation,